ESTIMATION OF VITAMIN D, HBA1C, AND LIPOPROTEIN LEVELS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CASE-CONTROL STUDY”

Main Article Content

Dr Amit Raj Jangade
Dr Harish Kumar Uraon
Dr. Savita Aharwal

Keywords

Type-2 Diabetes Mellitus, Vitamin D, HbA1C, Apo-B, Lipid Profile, Insulin Resistance.

Abstract

Introduction: Type-2 Diabetes Mellitus (T2DM) is a global health burden with increasing prevalence and associated complications. Emerging evidence highlights the role of Vitamin D in glycaemic control and lipid metabolism.


Objective: To estimate and analyse the levels of Vitamin D, HbA1C, and lipoproteins in T2DM patients and evaluate their interrelationship.


Methods: A case-control study was conducted from April 2023 to September 2024 involving 100 participants (50 T2DM patients and 50 healthy controls). Vitamin D, HbA1C, lipid profile, and ApoB levels were measured using ELISA, HPLC, nephelometry, and automated analysers. Statistical correlations among the biomarkers were evaluated.


Results: T2DM patients showed significantly lower Vitamin D levels and elevated HbA1C and ApoB levels compared to controls. A negative correlation was observed between Vitamin D and HbA1C, and between Vitamin D and ApoB levels, indicating possible interdependence in metabolic regulation.


Conclusion: Vitamin D deficiency may contribute to poor glycaemic control and dyslipidaemia in T2DM. Monitoring Vitamin D alongside HbA1C and lipid profile can help in comprehensive diabetes management.

Abstract 57 | pdf Downloads 21

References

1. International Diabetes Federation. IDF Diabetes Atlas, 10th ed. Brussels, Belgium: 2021.
2. Anjana RM, et al. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR–INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol. 2017;5(8):585–596.
3. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–281.
4. Chiu KC, et al. Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. Am J Clin Nutr. 2004;79(5):820–825.
5. Maestro B, et al. Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D3. Cell Biochem Funct. 2002;20(3):227–232.
6. American Diabetes Association. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes—2022. Diabetes Care. 2022;45(Suppl 1):S17–S38.
7. Goldberg IJ. Diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab. 2001;86(3):965–971.
8. Sniderman AD, et al. Apolipoprotein B versus non–high-density lipoprotein cholesterol: and versus LDL cholesterol: when and why. J Clin Lipidol. 2008;2(5):286–293.
9. Szymczak-Pajor I, et al. Vitamin D and its analogs in type 2 diabetes prevention and treatment. Int J Mol Sci. 2020;21(13):4635.
10. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92(6):2017–2029.
11. Maestro B, Dávila N, Carranza MC, Calle C. Identification of a Vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol. 2003;84(2-3):223–230.
12. Alvarez JA, Ashraf A. Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol. 2010;2010:351385.
13. Mitri J, Dawson-Hughes B, Hu FB, Pittas AG. Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr. 2011;94(2):486–494.
14. Dutta D, Mondal SA, Choudhuri S, et al. Vitamin D supplementation in prediabetes reduced progression to type 2 diabetes and was associated with decreased insulin resistance. J Diabetes. 2014;6(5):512–519.
15. Sniderman AD, St-Pierre AC, Cantin B, Dagenais GR, Després JP, Lamarche B. Concordance/discordance between plasma apolipoprotein B levels and LDL particle concentration in the prediction of ischemic heart disease risk. Circulation. 2003;107(20):2417–2422.
16. Jorde R, Grimnes G. Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res. 2011;50(4):303–312.
17. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72(3):690–693.